Accession Number: | 0000899243-21-024521 |
Date: | 2021-06-15 |
Issuer: | AILERON THERAPEUTICS INC (ALRN) |
Original Submission Date: |
ANNIS ALLEN
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.29 | 2021-06-15 | deemed execution date | A | 474,000 (a) | 2031-06-14 | common stock 474,000 | $1.29 | 474,000 | direct |
ID | footnote |
---|---|
f1 | this option was granted on june 15, 2021. the shares underlying the option are scheduled to vest as to 25% of the shares on june 15, 2022 and thereafter in equal monthly installments through june 15, 2025. |